AstraZeneca
AZN
AZN
1,053 hedge funds and large institutions have $35B invested in AstraZeneca in 2023 Q1 according to their latest regulatory filings, with 87 funds opening new positions, 406 increasing their positions, 348 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
0.1% less ownership
Funds ownership: 32.87% → 32.77% (-0.1%)
1% less funds holding
Funds holding: 1,059 → 1,053 (-6)
32% less funds holding in top 10
Funds holding in top 10: 19 → 13 (-6)
Holders
1,053
Holding in Top 10
13
Calls
$487M
Puts
$466M
Top Buyers
| 1 | +$733M | |
| 2 | +$293M | |
| 3 | +$274M | |
| 4 |
Morgan Stanley
New York
|
+$184M |
| 5 |
Goldman Sachs
New York
|
+$103M |
Top Sellers
| 1 | -$657M | |
| 2 | -$205M | |
| 3 | -$180M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$131M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$126M |